# KETOROLAC TROMETHAMINE
> **ANDA221041** · Abbreviated New Drug Application (Generic) · Sponsor: ADAPTIS · Approved 2026-09-25
## Drug
- **FDA Application Number:** ANDA221041
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** KETOROLAC TROMETHAMINE
- **Generic name:** Ketorolac Tromethamine
- **Active ingredients:** KETOROLAC TROMETHAMINE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** ADAPTIS
- **First approval:** 2026-09-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=221041)
---
*MORVS · CC0 1.0*